Left Ventricular Remodeling
📧 Sign up to get email alerts when something new happens for Left Ventricular Remodeling.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Prediction of LVAR and MACE in AMI Though Plasma Multiomics Analysis
This clinical trial investigates using plasma multiomics to predict left ventricular remodeling and major adverse cardiovascular events in p…
-
CLINICAL_TRIALS withdrawal · 2025-04-10Clinical Trial Update: ALIVE Expended Access - Clinical Study
The ALIVE Expanded Access clinical study sponsored by BioVentrix has been closed and is no longer available.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients [Phase 4]
Phase 4 trial evaluating valsartan to prevent left ventricle remodeling in patients with a first-time dual-chamber pacemaker implantation; t…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation [Phase 2]
Phase 2 clinical trial comparing ARni with ARB in patients with elevated natriuretic peptide; status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI [Phase 2, Phase 3]
Phase 2/3 trial evaluating methotrexate delivered via lipid nanoemulsion for effects on left ventricular remodeling after anterior wall myoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER) [Phase 2, Phase 3]
A phase 2/3 trial investigating whether glucocorticoid therapy affects left ventricular remodeling after ST-segment elevation myocardial inf…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study [Phase 4]
Phase 4 pilot study examining phosphodiesterase type 5 inhibition in aortic stenosis; trial terminated with posted results.
-
CLINICAL_TRIALS research · 2018-03-29Clinical Trial Update: IMproving reModeling in Acute myoCardial Infarction Using Live and Asynchronous TElemedicine. [NA]
Clinical trial update from Singapore investigates improving remodeling after acute myocardial infarction using live and asynchronous telemed…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction [Phase 4]
This is a Phase 4 clinical trial update evaluating Sodium Tanshinone IIA Sulfonate for left ventricular remodeling following an acute myocar…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Danlou Tablets to Prevent Left Ventricular Remodeling [Phase 4]
A Phase 4 clinical trial evaluating Danlou Tablets to prevent left ventricular remodeling following acute myocardial infarction has complete…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling
This completed clinical trial evaluates circulating microRNA-126 as a biomarker for remodeling after myocardial infarction.